₩1,278,000-2.44%
2026-10-07 closeSamsung Biologics's published financial data is dated 2026-10-04. 2024 revenue was KRW 4.55T. 2024 operating profit was KRW 1.26T.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy
Samsung Biologics's published financial data is dated 2026-10-04. 2024 revenue was KRW 4.55T. 2024 operating profit was KRW 1.26T.